InvestorCamford Capital is an early-stage venture capital firm based in Menlo Park, California, focusing on investments across technology and healthcare sectors. The firm leverages a diverse team to support its portfolio companies.

Utopia SIS SpA is an Italian venture capital firm based in Bologna, focused on investing in high-growth startups within the life sciences sector. The firm primarily targets Seed and Series A investments in innovative healthcare projects.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Utopia SIS SpA is an investment company based in Italy, established to invest in high-growth projects within the Life Sciences sector. The organization aims to address the significant gap in venture capital investments in Italy compared to other European countries. Utopia focuses on investing in startups that contribute to collective well-being across the value chain. The firm targets Seed and Series A stages, emphasizing scientific merit and innovative solutions in areas such as disease-modifying drugs, medical devices, and healthcare AI. Notable portfolio companies include Novavido Srl and PerFormS Srl, showcasing Utopia's commitment to advancing healthcare through strategic investments.
Utopia SIS SpA invests primarily in Seed and Series A stages within the Life Sciences sector. Their investment focus includes disease-modifying drugs, medical devices, diagnostic tools and biomarkers, and cross-border applications of Artificial Intelligence in healthcare. The organization seeks innovative projects that develop potential therapies for unmet medical needs and emphasizes the scientific merit of the companies they evaluate.
Utopia SIS SpA adds value to its portfolio companies by providing strategic guidance, scientific expertise, and access to a network of industry contacts, helping startups navigate the complexities of the life sciences sector.
Utopia SIS SpA invests in Seed and Series A stages, focusing on innovative projects within the Life Sciences sector that address unmet medical needs.
Founders can pitch their startups by visiting the Utopia SIS SpA website and using the contact email provided. A detailed pitch deck should be included, highlighting the scientific merit and potential impact of the project.
The firm specifically targets the Life Sciences sector in Italy, aiming to fill the venture capital gap in the region and focusing on scientific merit in their investment decisions.
Utopia SIS SpA primarily invests in startups based in Europe, particularly those that are innovating within the Life Sciences sector.
Utopia SIS SpA provides operational support and strategic guidance to its portfolio companies, helping them navigate the complexities of the healthcare market.
While specific check sizes are not disclosed, Utopia SIS SpA focuses on Seed and Series A investments, which typically range from several hundred thousand to a few million euros.
Superscout Pro
Is this page right?Reviewed · How the research works